Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 4
2004 1
2006 3
2007 1
2011 1
2015 1
2016 1
2017 1
2018 1
2020 3
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

17 results
Results by year
Filters applied: . Clear all
Page 1
Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial.
Seibold JR, Maher TM, Highland KB, Assassi S, Azuma A, Hummers LK, Costabel U, von Wangenheim U, Kohlbrenner V, Gahlemann M, Alves M, Distler O; SENSCIS trial investigators. Seibold JR, et al. Among authors: kohlbrenner v. Ann Rheum Dis. 2020 Nov;79(11):1478-1484. doi: 10.1136/annrheumdis-2020-217331. Epub 2020 Aug 5. Ann Rheum Dis. 2020. PMID: 32759258 Free PMC article. Clinical Trial.
Disease frequency, patient characteristics, comorbidity outcomes and immunosuppressive therapy in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: a US cohort study.
Li Q, Wallace L, Patnaik P, Alves M, Gahlemann M, Kohlbrenner V, Raabe C, Wang JR, Garry EM. Li Q, et al. Among authors: kohlbrenner v. Rheumatology (Oxford). 2021 Apr 6;60(4):1915-1925. doi: 10.1093/rheumatology/keaa547. Rheumatology (Oxford). 2021. PMID: 33155024 Free PMC article.
Once-a-day therapy for sinusitis: a comparison study of cefixime and amoxicillin.
Edelstein DR, Avner SE, Chow JM, Duerksen RL, Johnson J, Ronis M, Rybak LP, Bierman WC, Matthews BL, Kohlbrenner VM. Edelstein DR, et al. Among authors: kohlbrenner vm. Laryngoscope. 1993 Jan;103(1 Pt 1):33-41. doi: 10.1288/00005537-199301000-00008. Laryngoscope. 1993. PMID: 8421417 Review.
17 results